Haemonetics (HAE) Non-Current Assets (2010 - 2026)

Haemonetics has reported Non-Current Assets for 17 years, with the latest figure at $1.6 billion in Q1 2026.

• For the quarter ending Q1 2026, Non-Current Assets rose 2.97% year-over-year to $1.6 billion; the trailing twelve-month figure through Mar 2026 stood at $6.2 billion (changed 0.43% YoY), and the FY2026 full-year result was $1.6 billion, up 2.97% from the prior year.
• Non-Current Assets for Q1 2026 stood at $1.6 billion, up from $1.5 billion in the prior quarter.
• The five-year high for Non-Current Assets was $1.6 billion in Q3 2024, with the low at $1.1 billion in Q1 2022.
• Average Non-Current Assets over 5 years is $1.4 billion, with a median of $1.4 billion recorded in 2023.
• Peak annual rise in Non-Current Assets reached 69.6% in 2022, while the deepest fall reached 2.01% in 2022.
• Tracing HAE's Non-Current Assets over 5 years: stood at $1.2 billion in 2022, then climbed by 22.5% to $1.4 billion in 2023, then rose by 6.27% to $1.5 billion in 2024, then rose by 1.43% to $1.5 billion in 2025, then increased by 0.89% to $1.6 billion in 2026.
• The last three Non-Current Assets figures came in at $1.6 billion (Q1 2026), $1.5 billion (Q4 2025), and $1.5 billion (Q3 2025), per Business Quant data.

Peer Comparison